Finally, a total of 45 hub genes were identified, among which four hub genes (SRGN, PLEK, and FCGR3B) were predicted to be upregulated in UC and RA samples (GSE38713 and GSE1919) and downregulated in UC patients with response to infliximab treatment (GSE12251). Here, SRGN is linked to rheumatoid arthritis.